Innovative Therapeutics

From 2001 to 2014, health care expenditure in Australia doubled to $140 billion (9.5% GDP), and has since been increasing at a rate of 7.7% per annum. The various tiers of government fund 68% of these costs, 11.5% of which can be attributed to pharmaceuticals alone.

The development of new and cost-effective therapeutics is critical for sustaining and advancing the delivery of health care to the Australian community. Our research aims to produce novel therapeutic approaches to enhance efficacy and specificity; lower the side effects; provide greater safety; and reduced need for hospitalisation or other health services. 

Researchers across the faculty are focused on:

• identifying novel targets for therapy to prevent metastasis and modulate the progression of cancers
• identifying new biomarkers to identify disease, predict disease trajectories and monitor response to treatment
• developing tissue regeneration technologies to address tissue injuries and disease
• developing cost-effective in vitro models to replace animal models for testing therapeutic efficacy
• developing rigorous clinical evaluation approaches of novel combinations of existing therapeutic agents, including development of novel modes of delivery.